DIMMITROL HEARTWORM TABLET 50MG

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

DIETHYLCARBAMAZINE CITRATE

Available from:

MAVLAB PTY. LTD.

INN (International Name):

diethylcarbamazine citrate(50mg/Tb)

Pharmaceutical form:

ORAL TABLET

Composition:

DIETHYLCARBAMAZINE CITRATE CARBAMATE-ETHYLCARBAMATE Active 50.0 mg/Tb

Units in package:

100 Tabs

Class:

VM - Veterinary Medicine

Therapeutic group:

DOG | BITCH | CASTRATE | PUPPY

Therapeutic area:

PARASITICIDES

Therapeutic indications:

HEARTWORM - PREVENTION OF | TO PREVENT HEARTWORM

Product summary:

Poison schedule: 0; Withholding period: WHP: Nil; Host/pest details: DOG: [HEARTWORM - PREVENTION OF]; Poison schedule: 0; Withholding period: ; Host/pest details: DOG: [HEARTWORM - PREVENTION OF]; For the prevention of heartworm disease in dogs.Consult a veterinarian before use. Adverse reactions may occur when administering this product to dogs for prevention of heartworm.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

FOR ANIMAL TREATMENT ONLY
DIMMITROL HEARTWORM TABLET
ACTIVE CONSTITUENT
: 50 mg per tablet
DIETHYLCARBAMAZINE CITRATE (equivalent to
25.5 mg DIETHYLCARBAMAZINE)
For the prevention of heartworm disease (
_Dirofilaria_
_immitis_
) in dogs.
Net Contents:
100 TABLETS
Mavlab logo
We Do Care
33 Rowland St., Slacks Creek, Qld 4127
DIRECTIONS FOR USE
:
Administer daily to dogs after two weeks of age at the
rate of 5.5 mg/kg bodyweight (BW) or
WEIGHT (KG)
TABLETS PER DAY
Up to 2.5
1/4
2.5-4.5
1/2
4.5-9
1
WARNING
: Administer to dogs free of microfilariae.
Consult a veterinarian before use. Adverse reactions
may occur when administering this product to dogs for
prevention of heartworm
STORAGE
: Store below 30
°
C. (Room Temperature).
Replace lid tightly after use.
DISPOSAL
:
Dispose of empty container by wrapping
in paper and placing in garbage.
NRA Approval No.
Expiry
Batch No.
2400/93/A
HH18123
FOR ANIMAL TREATMENT ONLY
DIMMITROL HEARTWORM TABLET
ACTIVE CONSTITUENT
: 50 mg per tablet
DIETHYLCARBAMAZINE CITRATE (equivalent to
25.5 mg DIETHYLCARBAMAZINE)
For the prevention of heartworm disease (
_Dirofilaria_
_immitis_
) in dogs.
Net Contents:
100 TABLETS
Mavlab logo
We Do Care
33 Rowland St., Slacks Creek, Qld 4127
DIRECTIONS FOR USE
:
Administer daily to dogs after two weeks of age at the
rate of 5.5 mg/kg bodyweight (BW) or
WEIGHT (KG)
TABLETS PER DAY
Up to 2.5
1/4
2.5-4.6
1/2
4.5-9
1
WARNING
: Administer to dogs free of microfilariae.
Consult a veterinarian before use. Adverse reactions
may occur when administering this product to dogs for
prevention of heartworm
STORAGE
: Store below 30
°
C. (Room Temperature).
Replace lid tightly after use.
DISPOSAL
:
Dispose of empty container by wrapping
in paper and placing in garbage.
NRA Approval No.
Expiry
Batch No.
2400/93/A
HH18123
Info
PEST
✔
Verified
37418/1000
37418/1000

Summary of Product characteristics

MAVLAB PTY LTD
Date of Issue:
October 2007
MATERIAL SAFETY DATA SHEET
DIMMITROL HEARTWORM TABLETS 50 MG
Page 1 of 4
MSDS version:
3
Date of Revision:
October, 2007
Update of section:
All sections
SECTION 1 IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Product (material) name:
Dimmitrol Heartworm Tablet 50mg
Other names:
P2400
Recommended use:
Prevention of canine heartworm
Supplier Details:
Mavlab Pty Ltd ACN 068 507 148
33 Rowland Street
SLACKS CREEK QLD 4127
Contact Person:
Dr Paul Ross
Emergency Telephone:
[phone]
Facsimile:
[phone]
SECTION 2 HAZARDS IDENTIFICATION
This product is classified as dangerous goods under the Australian
Dangerous Goods Code and hazardous according
to the classification criteria of NOHSC:1008(2004), Approved Criteria
For Classifying Hazardous Substances and
the National Code of Practice for the Preparation of Material Safety
Data Sheets 2
nd
Edition [NOHSC:2011(2003)].
The following risk and safety phrases apply to diethylcarbamazine
citrate (DECC), the active constituent in these
tablets. The percentage of DECC in the tablets is above the
concentration cut-off that would enable the product to be
considered as not hazardous.
Risk phrases:
R21/22:
Harmful in contact with skin and if swallowed.
R26:
Toxic by inhalation.
R36/37/38:
Irritating to eye, to respiratory system and skin.
Safety phrases:
S22:
Do not breathe dust.
S24/25:
Avoid contact with skin and eyes.
S26:
In case of contact with eyes, rinse immediately with plenty of water
and seek medical
advice.
S28:
After contact with skin, wash immediately with plenty of water.
S62:
If swallowed, do not induce vomiting, seek medical advice immediately
and show this
container label.
S36/37/39:
Wear suitable protective clothing, gloves and eye/face protection. In
case of
accident or if you feel unwell seek medical advice immediately.
S38:
In case of insufficient ventilation, wear suitable respiratory
equipment.
SECTION 3 COMPOSITION/INFORMATION ON INGREDIENTS
INGREDIENTS
Cas No.
Proportion
Diethylcarbamazine Citrate (DECC)
16